![PRD_000621 PRD_000621](https://data.pdbj.org/pdbjplus/data/cc/svg/00Q.svg) | PRD_000621 | Name: | D-phenylalanyl-N-{(1S)-1-[(S)-1,3-benzothiazol-2-yl(hydroxy)methyl]-4-carbamimidamidobutyl}-L-prolinamide | Formula: | C27 H35 N7 O3 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000622 PRD_000622](https://data.pdbj.org/pdbjplus/data/cc/svg/QWE.svg) | PRD_000622 | Name: | amino{[(4S)-4-({[5-(dimethylamino)naphthalen-1-yl]sulfonyl}amino)-5-oxo-5-{(2R)-2-[3-oxo-3-(1,3-thiazol-2-yl)propyl]pip
eridin-1-yl}pentyl]amino}methaniminium | Formula: | C29 H40 N7 O4 S2 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000623 PRD_000623](https://data.pdbj.org/pdbjplus/data/cc/svg/1Z0.svg) | PRD_000623 | Name: | N-methyl-D-phenylalanyl-N-{(1S)-4-carbamimidamido-1-[(6-carboxy-1,3-benzothiazol-2-yl)carbonyl]butyl}-L-prolinamide | Formula: | C29 H35 N7 O5 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000628 PRD_000628](https://data.pdbj.org/pdbjplus/data/cc/svg/CCR.svg) | PRD_000628 | Name: | [N-[N-(4-METHOXY-2,3,6-TRIMETHYLPHENYLSULFONYL)-L-ASPARTYL]-D-(4-AMIDINO-PHENYLALANYL)]-PIPERIDINE | Formula: | C29 H39 N5 O7 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000630 PRD_000630](https://data.pdbj.org/pdbjplus/data/cc/svg/FYQ.svg) | PRD_000630 | Name: | N~2~-{(2R)-4-(methylamino)-4-oxo-2-[4-(phosphonooxy)benzyl]butanoyl}-L-glutaminyl-L-aspartamide | Formula: | C21 H31 N6 O10 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000632 PRD_000632](https://data.pdbj.org/pdbjplus/data/cc/svg/AYI.svg) | PRD_000632 | Name: | (1R,2S,3R,1S',1S")Phosphoric acid mono(4-{2-[1-(1,2-dicarbamoylethylcarbamoyl)-3-carbamoylpropylcarbamoyl]-3-methylcarbamoylcyclopropyl}phenyl) ester | Formula: | C22 H32 N5 O9 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000633 PRD_000633](https://data.pdbj.org/pdbjplus/data/cc/svg/AYQ.svg) | PRD_000633 | Name: | N~2~-({(1R,2R,3S)-2-(methylcarbamoyl)-3-[4-(phosphonooxy)phenyl]cyclopropyl}carbonyl)-D-glutaminyl-D-aspartamide | Formula: | C21 H29 N6 O10 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000634 PRD_000634](https://data.pdbj.org/pdbjplus/data/cc/svg/FYI.svg) | PRD_000634 | Name: | N-{(2S)-4-(methylamino)-4-oxo-2-[4-(phosphonooxy)benzyl]butanoyl}-L-isoleucyl-L-aspartamide | Formula: | C22 H34 N5 O9 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000635 PRD_000635](https://data.pdbj.org/pdbjplus/data/cc/svg/YEN.svg) | PRD_000635 | Name: | N-{(2S)-4-(methylamino)-4-oxo-2-[4-(phosphonooxy)benzyl]butanoyl}-L-alpha-glutamyl-L-aspartamide | Formula: | C21 H30 N5 O11 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000638 PRD_000638](https://data.pdbj.org/pdbjplus/data/cc/svg/RDF.svg) | PRD_000638 | Name: | N-ALPHA-L-RHAMNOPYRANOSYLOXY(HYDROXYPHOSPHINYL)-L-LEUCYL-L-TRYPTOPHAN | Formula: | C23 H34 N3 O10 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000639 PRD_000639](https://data.pdbj.org/pdbjplus/data/cc/svg/5FE.svg) | PRD_000639 | Name: | 5,5,5-TRIFLUORO-3-HYDROXY-4-[2-(5,5,5-TRIFLUORO-3-HYDROXY-4-{3-METHYL-2-[3-METHYL-2-(3-METHYL-BUTYRYLAMINO)-BUTYRYLAMINO]-BUTYRYLAMINO}-PENTANOYLAMINO)-PROPIONYLAMINO]-PENTANOIC ACID METHYL ESTER | Formula: | C29 H47 F6 N5 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000640 PRD_000640](https://data.pdbj.org/pdbjplus/data/cc/svg/5FP.svg) | PRD_000640 | Name: | 5,5,5-TRIFLUORO-3-HYDROXY-4-[2-(5,5,5-TRIFLUORO-3-HYDROXY-4-{3-METHYL-2-[3-METHYL-2-(3-METHYL-BUTYRYLAMINO)-BUTYRYLAMINO]-BUTYRYLAMINO}-PENTANOYLAMINO)-PROPIONYLAMINO]-PENTANOIC ACID | Formula: | C28 H45 F6 N5 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000641 PRD_000641](https://data.pdbj.org/pdbjplus/data/cc/svg/A02.svg) | PRD_000641 | Name: | (10R,20R,23R)-10-(4-aminobutyl)-1-[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]-20,23-bis(3-carbamimidamidopropyl)-1,8,11,18,21-pentaoxo-2,9,12,19,22-pentaazatetracosan-24-amide | Formula: | C40 H70 N18 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000642 PRD_000642](https://data.pdbj.org/pdbjplus/data/cc/svg/A03.svg) | PRD_000642 | Name: | (10R,20R,23R)-1-[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]-20,23-bis(3-carbamimidamido
propyl)-10-methyl-1,8,11,18,21-pentaoxo-2,9,12,19,22-pentaazatetracosan-24-amide | Formula: | C37 H63 N17 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000645 PRD_000645](https://data.pdbj.org/pdbjplus/data/cc/svg/ARX.svg) | PRD_000645 | Name: | (2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-N-(6-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-carbamoylbutyl]carbamoyl}butyl]amino}-6-oxohexyl)-3,4-dihydroxytetrahydrofuran-2-carboxamide | Formula: | C28 H47 N15 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000651 PRD_000651](https://data.pdbj.org/pdbjplus/data/cc/svg/UB2.svg) | PRD_000651 | Name: | N-[(S)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-L-alanyl-L-leucine | Formula: | C18 H28 N3 O7 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000652 PRD_000652](https://data.pdbj.org/pdbjplus/data/cc/svg/UB3.svg) | PRD_000652 | Name: | N-[(S)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-L-valyl-L-leucine | Formula: | C20 H32 N3 O7 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000653 PRD_000653](https://data.pdbj.org/pdbjplus/data/cc/svg/1U4.svg) | PRD_000653 | Name: | N-[(S)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-L-phenylalanyl-L-leucine | Formula: | C24 H32 N3 O7 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000654 PRD_000654](https://data.pdbj.org/pdbjplus/data/cc/svg/0PJ.svg) | PRD_000654 | Name: | N-[(S)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-L-leucyl-L-leucine | Formula: | C21 H34 N3 O7 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000655 PRD_000655](https://data.pdbj.org/pdbjplus/data/cc/svg/0PI.svg) | PRD_000655 | Name: | N-[(2R,4S)-4-hydroxy-2-(2-methylpropyl)-4-oxido-7-oxo-9-phenyl-3,8-dioxa-6-aza-4-phosphanonan-1-oyl]-L-leucine | Formula: | C21 H33 N2 O8 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000656 PRD_000656](https://data.pdbj.org/pdbjplus/data/cc/svg/0PK.svg) | PRD_000656 | Name: | N-[(S)-[(1R)-1-{[(benzyloxy)carbonyl]amino}-2-phenylethyl](hydroxy)phosphoryl]-L-leucyl-L-alanine | Formula: | C25 H34 N3 O7 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000657 PRD_000657](https://data.pdbj.org/pdbjplus/data/cc/svg/HH0.svg) | PRD_000657 | Name: | methyl N-[(2S)-2-({(S)-hydroxy[(1R)-3-methyl-1-{[N-(3-methylbutanoyl)-L-valyl-L-valyl]amino}butyl]phosphoryl}oxy)-3-phenylpropanoyl]-L-alanyl-L-alaninate | Formula: | C36 H60 N5 O10 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000659 PRD_000659](https://data.pdbj.org/pdbjplus/data/cc/svg/1Z7.svg) | PRD_000659 | Name: | N-(3-methylbutanoyl)-L-valyl-N-{(1S)-1-[(R)-[(1R)-1-benzyl-2-methoxy-2-oxoethoxy](hydroxy)phosphoryl]-3-methylbutyl}-L-
valinamide | Formula: | C30 H50 N3 O8 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000664 PRD_000664](https://data.pdbj.org/pdbjplus/data/cc/svg/IVV.svg) | PRD_000664 | Name: | N-(3-methylbutanoyl)-L-valyl-N-{(1R)-1-[(R)-(2-ethoxy-2-oxoethyl)(hydroxy)phosphoryl]-3-methylbutyl}-L-valinamide | Formula: | C24 H46 N3 O7 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000667 PRD_000667](https://data.pdbj.org/pdbjplus/data/cc/svg/2TS.svg) | PRD_000667 | Name: | (2S)-N-[[2-(aminomethyl)-5-chloro-phenyl]methyl]-1-[(2R)-5-carbamimidamido-2-(phenylmethylsulfonylamino)pentanoyl]pyrrolidine-2-carboxamide | Formula: | C26 H36 Cl N7 O4 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|